Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
25.54
-1.46 (-5.41%)
Nov 6, 2026, 4:00 PM EST - Market closed

Arcutis Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
29.91-16.14-140.04-262.14-311.46-206.36
Depreciation & Amortization
2.254.671.960.750.930.45
Asset Writedown & Restructuring Costs
----29.63-
Loss (Gain) From Sale of Investments
-0.56-2.09-6.9-6.99-2.253.45
Stock-Based Compensation
45.8740.3641.7338.8132.6823.89
Other Operating Activities
2.692.416.176.012.930.31
Change in Accounts Receivable
-56.17-73.16-47.26-17.35-8.46-
Change in Inventory
-22.26-7.33-0.4-5.62-7.51-
Change in Accounts Payable
2.55-1.692.233.151.570.25
Change in Other Net Operating Assets
55.6847.3630.35-3.684.233.38
Operating Cash Flow
59.96-5.63-112.16-247.06-257.72-174.63
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.26-0.69-0.14-0.43-0.33-1
Sale (Purchase) of Intangibles
--10-5--22.95-
Investment in Securities
-82.56-19.5733.96180.66-63.92-74.96
Investing Cash Flow
-82.82-30.2528.82180.23-87.2-75.95

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----12573.99
Long-Term Debt Repaid
---100---
Net Debt Issued (Repaid)
---100-12573.99
Issuance of Common Stock
10.236.97166.2101.32178.99209.6
Other Financing Activities
-1----2.19-1.64
Financing Cash Flow
9.236.9766.2101.32301.8281.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.120.17-0.24-0.05--
Net Cash Flow
-13.75-28.74-17.3734.45-43.1231.37

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
59.71-6.31-112.3-247.49-258.05-175.62
Free Cash Flow Growth
------
Free Cash Flow Margin
11.74%-1.68%-57.14%-415.20%-7000.76%-
Free Cash Flow Per Share
0.45-0.05-0.93-3.57-4.69-3.56
Levered Free Cash Flow
32.62-15.7-72.9-152.09-195.81-102.77
Unlevered Free Cash Flow
41.21-8.15-55.92-133.52-186.03-102.77

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
11.8310.3322.2125.4512.640.14
Change in Working Capital
-20.2-34.83-15.08-23.5-10.183.62
SEC Filings: 10-K · 10-Q